@article{oai:dmu.repo.nii.ac.jp:00005251,
 author = {Hirokawa, Hisanori and Hirata, Hirokuni and Kitajima, Ryo and Irokawa, Masahira and Ishiguro, Tomoyuki and Hasegawa, Tomoki and Sato, Junya and Ozaki, Atsutaka and Arima, Masafumi and Teramoto, Shinji and Haruki, Kosuke and Okamura, Takamitsu and Tamura, Hideto and Hashimoto, Koshi and Fukushima, Yasutsugu},
 issue = {2},
 journal = {Dokkyo Medical Journal},
 month = {Jun},
 note = {The patient was a 68-year-old woman who was hospitalized for SARS-CoV-2 pneumonia while receiving chemotherapy for B-cell lymphoma. She experienced repeated episodes of pneumonia that temporarily went into remission with steroid and remdesivir and but then relapsed or worsened. However, no particular subjective symptoms or deterioration on imaging was observed by an antibody cocktail treatment after Day 119. SARS-CoV-2 IgM and IgG antibody levels were below the limit of detection on Day 180 but she tested positive for SARS-CoV-2 by PCR on Day 151. In the case of this patient who had persistent SARS-CoV-2 infection due to being immunocompromised, treatment temporarily stalled the worsening of symptoms. However, new treatments for such patients should be established soon.},
 pages = {141--146},
 title = {A Case of Persistent SARS-CoV-2 PCR Positive after Chemotherapy for B-cell Lymphoma},
 volume = {1},
 year = {2022}
}